Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-21 Option Award | 2024-11-22 5:00 pm | N/A 2033-05-01 | Eledon Pharmaceuticals Inc. | ELDN | Smith Bryan E. General Counsel, Corporate Sec | 474,350 | $0 | 474,350 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 5:00 pm | N/A 2033-05-01 | Eledon Pharmaceuticals Inc. | ELDN | Smith Bryan E. General Counsel, Corporate Sec | 241,650 | $0 | 241,650 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-02 6:50 pm | N/A 2033-05-01 | Eledon Pharmaceuticals Inc. | ELDN | Smith Bryan E. General Counsel, Corporate Sec | 179,000 | $0 | 179,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-02 5:43 pm | N/A 2033-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Smith Bryan E. General Counsel, Corporate Sec | 155,000 | $0 | 155,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 5:37 pm | N/A 2032-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Smith Bryan E. General Counsel, Corporate Sec | 120,000 | $0 | 120,000 (Direct) | View |
| 2021-05-03 Option Award | 2021-05-04 4:27 pm | N/A 2031-05-03 | Eledon Pharmaceuticals Inc. | ELDN | Smith Bryan E. See Remarks | 158,500 | $0 | 158,500 (Direct) | View |
| 2021-03-29 Disposition | 2021-03-31 12:30 pm | N/A 2028-05-20 | Urovant Sciences Ltd. | UROV | Smith Bryan E. GC/Urovant Sciences, Inc. | 241,397 | $0 | 0 (Direct) | View |
| 2021-01-07 Tax Withholding | 2021-01-08 6:29 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Smith Bryan E. GC/Urovant Sciences, Inc. | 4,761 | $16.09 | 124,447 (Direct) | View |
| 2020-05-01 Option Award | 2020-05-04 4:55 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Smith Bryan E. GC/Urovant Sciences, Inc. | 77,606 | $0 | 127,606 (Direct) | View |
| 2020-02-19 Exercise | 2020-02-21 6:42 pm | N/A 2029-01-06 | Urovant Sciences Ltd. | UROV | Smith Bryan E. GC/Urovant Sciences, Inc. | 50,000 | $0 | 85,165 (Direct) | View |
| 2020-02-19 Exercise | 2020-02-21 6:42 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Smith Bryan E. GC/Urovant Sciences, Inc. | 50,000 | $6.88 | 85,165 (Direct) | View |
| 2020-02-19 Tax Withholding | 2020-02-21 6:42 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Smith Bryan E. GC/Urovant Sciences, Inc. | 34,835 | $13.08 | 85,165 (Direct) | View |
| 2020-02-19 Other | 2020-02-21 6:42 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Smith Bryan E. GC/Urovant Sciences, Inc. | 15,165 | $13.08 | 85,165 (Direct) | View |
| 2020-01-07 Option Award | 2020-01-09 4:30 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Smith Bryan E. GC/Urovant Sciences, Inc. | 50,000 | $0 | 50,000 (Direct) | View |